Association of prostate cancer polygenic risk score with number and laterality of tumor cores in active surveillance patients

Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

(2021) David V. Conti et al.   NATURE GENETICS

Genomic and phenotypic heterogeneity in prostate cancer

(2020) Michael C. Haffner et al.   Nature Reviews Urology

Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality: A Population-based Prospective Analysis

(2020) Zhuqing Shi et al.   EUROPEAN UROLOGY

Germline genetic variation in prostate susceptibility does not predict outcomes in the chemoprevention trials PCPT and SELECT

(2019) Mahbubl Ahmed et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

(2018) Fredrick R. Schumacher et al.   NATURE GENETICS

Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer

(2018) H. Ballentine Carter et al.   EUROPEAN UROLOGY

Reclassification of prostate cancer risk using sequentially identified SNPs: Results from the REDUCE trial

(2017) Haitao Chen et al.   PROSTATE

Clinical implications of family history of prostate cancer and genetic risk single nucleotide polymorphism (SNP) profiles in an active surveillance cohort

(2013) Chee L. Goh et al.   BJU INTERNATIONAL

Potential Impact of Adding Genetic Markers to Clinical Parameters in Predicting Prostate Biopsy Outcomes in Men Following an Initial Negative Biopsy: Findings from the REDUCE Trial

(2012) A. Karim Kader et al.   EUROPEAN UROLOGY

Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group

(2011) Donna P. Ankerst et al.   WORLD JOURNAL OF UROLOGY

Multifocal prostate cancer: biologic, prognostic, and therapeutic implications

(2010) Matei Andreoiu et al.   HUMAN PATHOLOGY

Tumor focality in prostate cancer: implications for focal therapy

(2010) Markos Karavitakis et al.   Nature Reviews Clinical Oncology

Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients

(2009) A. Karim Kader et al.   PROSTATE